155272-05-2 Usage
Molecular Structure
1H-Purine-2,6-dione, 3,7-dihydro-1,3-diethyl-8-(2-(4-hydroxyphenyl)ethenyl)-7-methyl-, (E)has a complex molecular structure that includes a purine ring, two ethyl groups, a 2,6-dione arrangement, and a (E)-8-(2-(4-hydroxyphenyl)ethenyl)-7-methyl side chain.
Purine Ring
The purine ring is a key structural component of this compound, which is similar to other purine-based compounds and plays a role in various metabolic processes.
Ethyl Groups
Two ethyl groups are attached to the purine ring, which may influence the compound's properties and activities.
2,6-Dione Arrangement
The presence of a 2,6-dione arrangement in the molecular structure may contribute to the compound's chemical reactivity and potential biological activity.
(E)-8-(2-(4-Hydroxyphenyl)ethenyl)-7-methyl Side Chain
This side chain is responsible for the compound's unique properties and potential biological activities, including antioxidant, anti-inflammatory, and enzymatic regulation.
Biological and Pharmaceutical Importance
Due to its structural similarity to purine-based compounds and its participation in various metabolic processes, this chemical has potential biological and pharmaceutical importance.
Potential Properties and Activities
The compound may exhibit a range of properties and activities, such as antioxidant, anti-inflammatory, or enzymatic regulation, making it a target for further research.
Therapeutic Applications
The potential properties and activities of this compound suggest that it may have therapeutic applications in the future, particularly in the areas of antioxidant, anti-inflammatory, and enzymatic regulation therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 155272-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,2,7 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 155272-05:
(8*1)+(7*5)+(6*5)+(5*2)+(4*7)+(3*2)+(2*0)+(1*5)=122
122 % 10 = 2
So 155272-05-2 is a valid CAS Registry Number.
InChI:InChI=1/C18H20N4O3/c1-4-21-16-15(17(24)22(5-2)18(21)25)20(3)14(19-16)11-8-12-6-9-13(23)10-7-12/h6-11,19H,4-5H2,1-3H3/b14-11+
155272-05-2Relevant articles and documents
An efficient route to xanthine based A2A adenosine receptor antagonists and functional derivatives
Labeaume, Paul,Dong, Ma,Sitkovsky, Michail,Jones, Elizabeth V.,Thomas, Rhiannon,Sadler, Sara,Kallmerten, Amy E.,Jones, Graham B.
supporting information; experimental part, p. 4155 - 4157 (2010/10/21)
A one-pot route to 8-substituted xanthines has been developed from 5,6-diaminouracils and carboxaldehydes. Yields are good and the process applicable to a range of substrates including a family of A2A adenosine receptor antagonists. A new route to the KW-6002 family of antagonists is presented including a pro-drug variant, and application to related image contrast agents developed.
Xanthine derivatives
-
, (2008/06/13)
The present invention relates to novel xanthine derivatives and pharmaceutically acceptable salts thereof, represented by Formula (I): STR1 wherein R1, R2, and R3 independently represent hydrogen, lower alkyl, lower alkeny
Therapeutic agent for Parkinson's disease
-
, (2008/06/13)
Agents for the treatment of Parkinson''s disease contain, as an active ingredient, a xanthine derivative or a pharmaceutically acceptable salt thereof. The xanthine derivative is represented by the formula: STR1 in which R 1, R 2 are R 3 are independently hydrogen, lower alkyl, lower alkenyl, or lower alkynyl; and R 4 represents cycloalkyl, --(CH 2) n --R 5 (in which R 5 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group; and n is an integer of 0 to 4), or STR2 in which Y 1 and Y 2 represent independently hydrogen, halogen, or lower alkyl; and Z represents substituted or unsubstituted aryl, STR3 in which R 6 represents hydrogen, hydroxy, lower alkyl, lower alkoxy, halogen, nitro, or amino; and m represents an integer of 1 to 4, or a substituted or unsubstituted heterocyclic group; and X 1 and X 2 represent independently O or S.
